NTRA:NASDAQ
Natera Inc
$319.09
arrow_downward
-1.19%(-3.85) 1D
$319.89
arrow_upward
+0.25% (+0.80)bedtimeAfter hours
Closed: Nov 13, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NTRA...
Open
$324.98
High
$324.98
Low
$312.08
Mkt. cap
46.27B
Avg. vol.
1.99M
Volume
1.69M
52-wk high
$437.41
52-wk low
$181.00
EPS
-$1.14
Beta
1.55
Shares outstanding
145.00M
No. of employees
6K
Open
$324.98
High
$324.98
Low
$312.08
Mkt. cap
46.27B
Avg. vol.
1.99M
Volume
1.69M
52-wk high
$437.41
52-wk low
$181.00
EPS
-$1.14
Beta
1.55
Shares outstanding
145.00M
No. of employees
6K
News stories
From web sources and news partners
Investing.com
·
4 hours ago
Natera co-founder Sheena sells $478,944 in common stock
Benzinga
·
16 hours ago
Micron, Moody’s, Digital Realty and a Health Care Stock on CNBC’s ‘Final Trades’
Yahoo Finance
·
1 day ago
How Incyte Trial And New Cancer Data Will Impact Natera Stock
Yahoo Finance
·
2 days ago
Strong Q2 Results and Raised Revenue Guidance Drive Natera’s (NTRA)Outperformance
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorHealth Care
IndustryBiotechnology
Websitenatera.com